Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Forbes Medi-Tech initiates dosing in trial of cholesterol drug
FM-VP4 is a cholesterol absorption inhibitor, a new class in cholesterol-lowering drugs. The drug may have an application as a monotherapy or as a combination therapy with statins.
FM-VP4 is a cholesterol absorption inhibitor, a new class in cholesterol-lowering drugs. The drug may have an application as a monotherapy or as a combination therapy with statins.
The agreement also settles the patent litigation relating to Barr’s generic version of the drug which its subsidiary Duramed Pharmaceuticals markets under the name Kariva. The deal includes
The FDA “approvable letter” is the second such setback that the company has suffered in its attempts to gain marketing approval for the drug in the US, and
The objectives of the trial are to determine safety, dose, pharmacokinetic profile and preliminary efficacy of Inno-105. The treatment is derived from a naturally occurring peptide that inhibits
While a number of studies published in the 1970s and 1980s indicated that small to moderate consumption of alcohol may help protect against heart disease, scientists at the
The collaboration will use Alder’s proprietary yeast production system and high throughput antibody selection system to identify and produce antibodies. Under terms of the agreement, Alder will work
The research and development is to be conducted in conjunction with researchers at the University of Pennsylvania, Duke University, and Beth Israel/Deaconess Hospital in Boston. Wyeth will develop
Under the expanded agreement, Lexicon will conduct advanced research on a broad subset of targets included in Genentech’s “secreted protein discovery initiative” program. These targets will be validated
Results of the phase II clinical study of R112 showed the treatment to be no more effective than placebo in reducing hay fever symptoms. The investigation compared Rigel’s
The QR-441 impregnated masks prevented up to 99% of the viruses whereas the masks not treated with the compound only had the ability to prevent up to 90%